Effectiveness of aspirin and clopidogrel combination therapy in coronary stenting
Coronary Artery Bypass
Coronary Artery Disease
Percutaneous Coronary Intervention
Two hundred fifty consecutive patients underwent coronary stenting and received a 2-week course of clopidogrel (75 mg orally each day after a loading dose of 150 mg) and aspirin. There was 1 (0.4%) in-hospital death, 1 (0.4%) acute stent thrombosis, and 2 (0.8%) subacute stent thromboses. There were no Q-wave myocardial infarctions, vascular complications, or repeat interventions at 30-day follow-up.